Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Sema4 (Nasdaq: SMFR) will announce its Q1 2022 financial results after the market closes on May 12, 2022. Following the results, a conference call hosted by CEO Eric Schadt and CFO Isaac Ro will take place at 4:30 p.m. ET to discuss operational and financial performance. Sema4 is focused on leveraging AI and machine learning to enhance healthcare through comprehensive data analysis via its health intelligence platform, Centrellis®. For more details, visit the company's investor relations website.
- Sema4 focuses on AI-driven genomic data to enhance healthcare.
- Introduction of Centrellis®, enhancing understanding of disease and wellness.
- None.
STAMFORD, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for the first quarter of 2022 after the market close on Thursday, May 12, 2022. On the same day, Eric Schadt, PhD, Founder and Chief Executive Officer of Sema4, and Isaac Ro, Chief Financial Officer of Sema4, will host a conference call to discuss financial and operating results at 4:30 p.m. ET.
Conference Call Details
The conference call will begin at 4:30 p.m. ET on Thursday, May 12, 2022. Interested parties may access the live teleconference by dialing (844) 631-4065 for domestic callers or (929) 517-0920 for international callers, followed by conference ID: 6568437. A live and archived webcast of the event will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.
About Sema4
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.
Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com
Media Contact:
Radley Moss
Sema4
radley.moss@sema4.com
FAQ
When will Sema4 release its Q1 2022 financial results?
What is the purpose of Sema4's conference call on May 12, 2022?
Who will host the conference call for Sema4's Q1 2022 results?
What is the stock symbol for Sema4?
